Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
08/08/2002 | US20020107406 Calcium receptor-active compounds |
08/08/2002 | US20020107345 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical |
08/08/2002 | US20020107280 Selective COX II inhibitor |
08/08/2002 | US20020107264 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
08/08/2002 | US20020107252 Novel Compounds |
08/08/2002 | CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
08/08/2002 | CA2434853A1 Chemical compounds |
08/07/2002 | EP1229010A1 Novel diarylamide derivatives and use thereof as medicines |
08/07/2002 | EP1228759A2 Pharmaceutical compositions containing a taxane having a furyl or thienyl substituted side-chain |
08/07/2002 | EP1228066A2 Sulfonamide derivatives |
08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
08/07/2002 | EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp) |
08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
08/07/2002 | EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
08/07/2002 | EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
08/07/2002 | CN1362956A C7 carbamoyloxy substituted taxanes as antitumor agents |
08/07/2002 | CN1362951A Dihetero-substituted metalloprotease inhibitors |
08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
08/07/2002 | CN1088705C Thienylsulfonyamino (THIO) carbonyl compounds |
08/07/2002 | CN1088704C Process for synthesising of benzothiophenes |
08/06/2002 | US6429318 Metal halide layer and hydrogen halide salt of organic diamine are contacted; salt formation, supersaturation, precipitation |
08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
08/06/2002 | US6429312 N-aminoalkyldibenzothiopencarboxamide receptor subtype specific ligands |
08/06/2002 | US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
08/06/2002 | US6428780 Modified amino acid |
08/01/2002 | WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
08/01/2002 | WO2002059074A1 Benzylamine analogue |
08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
08/01/2002 | WO2002058658A1 Primary intermediates for oxidative coloration of hair |
08/01/2002 | WO2002058657A1 Primary intermediates for oxidative coloration of hair |
08/01/2002 | WO2002058631A2 Primary intermediates for oxidative coloration of hair |
08/01/2002 | WO2002040431A3 Compounds having fungicidal activity and processes to make and use same |
08/01/2002 | WO2002026733A3 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
08/01/2002 | US20020103256 Contacting helminth, nematode, insect or acarid pests or parasites or their food supply, habitat or breeding grounds with a nitroethyl derivative |
08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
08/01/2002 | US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
08/01/2002 | US20020103198 Acylamino cyclopropane derivatives |
08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
08/01/2002 | CA2435883A1 Benzylamine analogue |
08/01/2002 | CA2435647A1 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
08/01/2002 | CA2434311A1 4-amino-2-(1-aryloxy-ethyl)phenol compounds as primary intermediates for oxydative coloration of hair |
08/01/2002 | CA2433686A1 Primary intermediates for oxidative coloration of hair |
07/31/2002 | EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain |
07/31/2002 | EP1226135A2 Method for preparing a thiophene derivative |
07/31/2002 | EP1226133A2 N-SUBSTITUTED 3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES AND 1,4-THIOBUTYROLACTONES FOR USE AS PROMOTER OF $g(g)-AMINOBUTYRIC ACID ACTIVITY AND FOR TREATING NERVOUS DISORDERS AND PREPARATION METHOD |
07/31/2002 | EP1226108A1 Diaryl-enynes |
07/31/2002 | EP0527801B1 Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
07/31/2002 | CN1361778A Substituted thiene-3-yl-sulfonyl amino (thio) carbonyl-triazolin (thi) ones |
07/31/2002 | CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
07/31/2002 | CN1360890A Use of active retiene derivative with negative hormone and/or antagonist |
07/30/2002 | US6426417 Processes and intermediates useful to make antifolates |
07/30/2002 | US6426365 CETP activity inhibitors |
07/30/2002 | US6426364 Nervous system or psychological disorders |
07/30/2002 | US6426354 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
07/30/2002 | CA2228997C Benzothiophene compounds |
07/25/2002 | WO2002057252A2 Heterocyclic sulfonamide inhibitors of beta amyloid production |
07/25/2002 | WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists |
07/25/2002 | WO2002057224A2 Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' |
07/25/2002 | WO2002057220A1 Hydrazide derivatives and pharmaceutical compositions containing same |
07/25/2002 | WO2002057219A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
07/25/2002 | WO2002057215A2 Sodium channel modulators |
07/25/2002 | WO2002056827A2 Substituted felbamate derived compounds |
07/25/2002 | WO2001000609A9 Method for synthesis of n-homocysteine thiolactonyl retinamide |
07/25/2002 | US20020099220 Calcilytic compounds |
07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
07/25/2002 | US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
07/25/2002 | CA2434939A1 Urea derivatives as integrin alpha 4 antagonists |
07/25/2002 | CA2427058A1 Substituted felbamate derived compounds |
07/25/2002 | CA2425135A1 Synthesis and antimicrobial activity of novel dicationic "reversed amidines" |
07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
07/24/2002 | EP1224168A1 Antifungal enediynes |
07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
07/24/2002 | EP0979075A4 A REGIOSELECTIVE ALKYLATION PROCESS FOR PREPARING SUBSTITUTED BENZO b]THIOPHENES |
07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
07/24/2002 | CN1360573A Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
07/24/2002 | CN1360570A Phenyl sulfamate derivs. |
07/24/2002 | CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates |
07/24/2002 | CN1087937C Medicine of inhibiting Alzheimer's disease |
07/23/2002 | US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same |
07/23/2002 | US6423737 Benzamidoxime prodrugs as antipneumocystic agents |
07/23/2002 | US6423729 Therapeutic or prophylactic agent for glomerulopathy |
07/23/2002 | US6423727 Certain thiol inhibitors of endothelin-converting enzyme |
07/23/2002 | US6423717 Nervous system disorders |
07/18/2002 | WO2002055484A1 Biaryl compound, process for producing the same, and agent |
07/18/2002 | WO2002055025A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
07/18/2002 | WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
07/18/2002 | WO2001072685A3 Polyamine analogues as cytotoxic agents |
07/18/2002 | US20020095041 Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
07/18/2002 | US20020094979 Use of 5HT-6 antagonists |
07/18/2002 | US20020094935 N-([1,2,4] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides |